Boniva, also known as ibandronate sodium, is a prescription medication used to treat and prevent osteoporosis in postmenopausal women.
Osteoporosis is a condition in which bones become weak and brittle, making them more susceptible to fractures.
Boniva belongs to a class of drugs called bisphosphonates, which work by slowing down the breakdown of bone tissue and increasing bone density.
While Boniva is generally considered safe and effective, like any medication, it can have side effects. Some of the common side effects include gastrointestinal problems like nausea, diarrhea, and stomach pain.
In rare cases, it can also cause more serious side effects such as bone fractures and osteonecrosis of the jaw (ONJ), a condition where the jawbone becomes exposed and dies.
In recent years, the United States Food and Drug Administration (FDA) has issued warnings regarding the risk of ONJ associated with bisphosphonate use, including Boniva.
The FDA recommends that patients on bisphosphonates be aware of the signs and symptoms of ONJ, including jaw pain, swelling, and infection.
Despite these warnings, there have been no reports of Boniva being taken off the market. It is still a commonly prescribed medication for osteoporosis treatment and prevention.
If you have concerns about taking Boniva or any other medication, it’s important to discuss them with your healthcare provider.
They can help you weigh the potential benefits and risks of the medication and determine if it is the right choice for your individual needs.
It’s also important to note that there are alternative treatments for osteoporosis, such as lifestyle changes and other medications.
Your healthcare provider can help you explore these options and choose the best course of treatment for you. Overall, Boniva is still available on the market and continues to be a valuable tool in the fight against osteoporosis.
